Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B J Fessler

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Annals of the Rheumatic Diseases|November 5, 2005
Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXIV. Cytotoxic treatment is an additional risk factor for the development of symptomatic osteonecrosis in lupus patients: results of a nested matched case-control studyJ Calvo-Alén, G McGwin, S Toloza, et al.
Rheumatology (Oxford, England)|March 31, 2005
Systemic lupus erythematosus in a multiethnic US Cohort (LUMINA). XXX: association between C-reactive protein (CRP) gene polymorphisms and vascular eventsA J Szalai, G S Alarcón, J Calvo-Alén, et al.
Osteoarthritis and Cartilage|August 27, 2013
Experimental pain sensitivity differs as a function of clinical pain severity in symptomatic knee osteoarthritisC D King, K T Sibille, B R Goodin, et al.
Annals of the Rheumatic Diseases|September 7, 2011
Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosusJ G Hanly, M B Urowitz, L Su, et al.
Lupus|August 16, 2014
Anti-C1q antibodies in systemic lupus erythematosusA-M Orbai, L Truedsson, G Sturfelt, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Annals of the Rheumatic Diseases|November 5, 2005
Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXIV. Cytotoxic treatment is an additional risk factor for the development of symptomatic osteonecrosis in lupus patients: results of a nested matched case-control studyJ Calvo-Alén, G McGwin, S Toloza, et al.
Rheumatology (Oxford, England)|March 31, 2005
Systemic lupus erythematosus in a multiethnic US Cohort (LUMINA). XXX: association between C-reactive protein (CRP) gene polymorphisms and vascular eventsA J Szalai, G S Alarcón, J Calvo-Alén, et al.
Osteoarthritis and Cartilage|August 27, 2013
Experimental pain sensitivity differs as a function of clinical pain severity in symptomatic knee osteoarthritisC D King, K T Sibille, B R Goodin, et al.
Annals of the Rheumatic Diseases|September 7, 2011
Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosusJ G Hanly, M B Urowitz, L Su, et al.
Lupus|August 16, 2014
Anti-C1q antibodies in systemic lupus erythematosusA-M Orbai, L Truedsson, G Sturfelt, et al.
Pageof 4